rheumatoid arthritis(22) Safety(9) juvenile idiopathic arthritis(5) Janus kinase inhibitor(5) Tofacitinib(5) adalimumab(4) Etanercept(4) systemic lupus erythematosus(4) Upadacitinib(4) Efficacy(4) TNF inhibitors(3) Infection(3) Janus kinase inhibitors(3) Tocilizumab(3) psoriatic arthritis(3) infections(3) glucocorticoid(2) abatacept(2) Systemic sclerosis(2) Middle East(2) methotrexate(2) DMARDs (biologics)(2) pharmacokinetics(2) Japanese(2) spondyloarthritis(2) clinical trial(2) refractory(2) biological therapies(2) biologics(2) serious infection(2)